Suffolk Capital Management’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-80,979
Closed -$1.51M 146
2016
Q2
$1.51M Sell
80,979
-7,836
-9% -$163K 0.19% 128
2016
Q1
$2.4M Sell
88,815
-6,411
-7% -$184K 0.32% 93
2015
Q4
$2.87M Buy
95,226
+8,283
+10% +$266K 0.36% 75
2015
Q3
$2.75M Buy
86,943
+5,236
+6% +$191K 0.37% 73
2015
Q2
$3.18M Buy
81,707
+3,879
+5% +$134K 0.38% 66
2015
Q1
$2.76M Sell
77,828
-35,000
-31% -$1.13M 0.32% 95
2014
Q4
$3.56M Buy
112,828
+25,702
+29% +$711K 0.43% 61
2014
Q3
$1.95M Buy
+87,126
New +$1.74M 0.24% 117

Other funds holding PAHC

Suffolk Capital Management's PAHC Position: Q3 2016 in Review

Suffolk Capital Management sold out of Phibro Animal Health (PAHC) in Q3 2016, closing a stake of 80,979 shares — an estimated $1.51M sold.

Suffolk Capital Management first reported a position in PAHC in Q3 2014 and held it in 8 quarters. The position peaked at $3.56M in Q4 2014. 122 funds tracked by Wall St. Rank hold PAHC as of Q3 2016.

  • Suffolk Capital Management reported no remaining Phibro Animal Health position as of Q3 2016 after selling out during the quarter.
  • Suffolk Capital Management sold 80,979 Phibro Animal Health shares in Q3 2016, an estimated $1.51M.
  • Suffolk Capital Management first reported a position in Phibro Animal Health in Q3 2014 and held it in 8 quarters.
  • Suffolk Capital Management's Phibro Animal Health position peaked at $3.56M in Q4 2014.
  • 122 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2016.

Based on Suffolk Capital Management's 13F filing for Q3 2016, filed 31 Oct 2016.